查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1654282

研究蛋白質市場規模、佔有率、趨勢分析報告：按產品、宿主細胞、最終用途、地區和細分市場預測，2025 年至 2030 年

Research-grade Proteins Market Size, Share & Trends Analysis Report By Product, By Host Cell, By End-use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 130 Pages | 商品交期: 2-10個工作天內

價格

研究蛋白質市場的成長和趨勢

根據 Grand View Research, Inc. 的新報告，全球研究蛋白質市場規模預計到 2030 年將達到 17.5 億美元。

預計 2025 年至 2030 年間，市場複合年成長率為 11.49%。預計腫瘤學領域研發投入的增加和個人化藥物需求的增加將促進市場的成長。此外，許多國家政府對各種臨床研究的投資增加也有望推動市場成長。此外，新興國家生物技術產業的不斷進步將進一步推動預測期內的市場成長。

由於疫苗、診斷和治療開發研究活動的激增，COVID-19 大流行對市場產生了積極影響。隨著監管機構致力於加快候選疫苗的核准流程，對契約製造的需求增加。儘管 mRNA 疫苗等新型疫苗平台已引起廣泛關注，但幾種重組蛋白疫苗的替代品也正在接受評估。例如，2022 年 7 月，Novavax, Inc. 的新冠疫苗 (NVX-CoV2373) 獲得了在歐盟使用的擴大有條件上市核准。此外，此次疫情凸顯了生技藥品對敏捷和靈活製造能力的需求。預計這一因素將在不久的將來增強競爭格局並推動市場成長。

根據全球基因統計，截至2019年10月，全球有超過4億人患有罕見疾病或遺傳疾病。這些數字表明迫切需要改善治療、臨床環境和健康意識。對於藥物開發來說，對藥物標靶機制的先進研究和知識至關重要。許多地區正在透過隊列計劃建立生物庫，為研究人員提供高品質樣本，以徹底改變治療工作。因此，預計人們將更加關注發現各種疾病的生物標記。因此，預計研究力度的加大和政府對建設更好的醫療保健基礎設施的興趣將增強研究蛋白質的應用，從而推動市場成長。

然而，蛋白質生產是一個耗時的過程，通常需要高維護的工作條件。儘管對這些重組產品的需求很高且不斷成長，但監管機構的支持仍然進展緩慢。用於研究的蛋白質通常透過宿主或表現系統產生，其中透過轉染、細菌轉化或病毒轉導步驟來表達特異性於感興趣產品的基因。這個複雜的過程常常受到非目標區域的過度表現的影響，而且很耗時。因此，缺乏關於重組技術的具體指導方針和法規，成為研究蛋白質市場蓬勃發展的一大障礙。

研究級蛋白質市場報告重點

  • 按產品分類，細胞激素和生長因子部分將在 2024 年佔據市場主導地位，收益佔有率最大，為 23.61%，預計在預測期內複合年成長率最快，為 17.62%。這是因為它在藥物發現和開發的各種臨床試驗中發揮作用。
  • 按宿主細胞分類，哺乳動物細胞部分在 2024 年佔據市場主導地位，收益佔有率最大，為 55.73%。其巨大佔有率主要是因為它們的生物結構與人類細胞相似，有助於生產單株抗體和疫苗等生物製藥。
  • 根據最終用途，製藥和生物技術公司佔最大佔有率，到 2024 年將達到 61.48%。由於藥物發現和開發的研究活動增加以及個人化藥物的需求不斷增加，預計預測期內對研究蛋白質的需求將會增加。
  • 按地區分類，北美將佔據市場主導地位，到 2024 年其收入佔有率將達到 44.47%。這一巨大佔有率歸功於主要市場參與企業的存在和強大的醫療保健基礎設施。預計這些因素將在預測期內推動該地區的研究蛋白質市場的發展。

目錄

第 1 章研究蛋白質市場：調查方法與範圍

第 2 章。

  • 市場展望
  • 段簡介
  • 競爭格局概況

3. 研究蛋白質市場的變數、趨勢和範圍

  • 市場體系展望
    • 母市場展望
    • 相關/支持市場展望
  • 市場趨勢與展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 商業環境分析
    • PESTEL 分析
    • 波特五力分析
    • COVID-19影響分析

第4章 產品業務分析

  • 產品細分儀表板
  • 研究蛋白質市場：產品變異分析
  • 2018 年至 2030 年全球研究級蛋白質市場規模及趨勢分析（依產品分類）
  • 細胞激素和生長因子
    • 細胞激素和生長因子市場，2018-2030
    • 干擾素（IFN）
    • 白細胞介素(IL)
    • 其他
  • 抗體
    • 抗體，2018-2030
  • 免疫查核點蛋白
    • 免疫查核點蛋白市場，2018-2030
  • 病毒抗原
    • 病毒抗原市場，2018-2030
  • 酵素
    • 酵素市場，2018-2030
    • 激酶
    • 代謝酵素
    • 其他
  • 重組調節蛋白
    • 重組調節蛋白市場，2018 - 2030 年
  • 荷爾蒙
    • 荷爾蒙市場，2018-2030
  • 其他
    • 其他市場，2018-2030

5. 宿主細胞業務分析

  • 宿主細胞細分儀表板
  • 研究蛋白質市場：宿主細胞變異分析
  • 2018 年至 2030 年全球研究蛋白質市場規模及趨勢分析（按宿主細胞）
  • 哺乳動物細胞
    • 哺乳動物細胞市場，2018-2030
  • 細菌細胞
    • 細菌細胞市場，2018-2030
  • 酵母和真菌
    • 酵母和真菌市場，2018-2030
  • 昆蟲細胞
    • 昆蟲細胞市場，2018-2030
  • 其他
    • 其他市場，2018-2030

第6章 最終用途業務分析

  • 最終用途細分儀表板
  • 研究蛋白質市場：最終用途變異分析
  • 2018 年至 2030 年全球研究級蛋白質市場規模及趨勢分析（依最終用途）
  • 製藥和生物技術公司
    • 2018-2030 年製藥與生技市場
  • 學術研究所
    • 學術研究市場，2018-2030
  • 其他
    • 其他市場，2018-2030

第7章 區域經營分析

  • 區域控制面板
  • 2018-2030 年市場規模、預測及趨勢分析
  • 北美洲
    • 2018 至 2030 年北美研究蛋白質市場
    • 美國
    • 加拿大
  • 歐洲
    • 2018 至 2030 年歐洲研究蛋白質市場
    • 英國
    • 德國
    • 西班牙
    • 法國
    • 義大利
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 2018 年至 2030 年亞太地區研究蛋白質市場
    • 日本
    • 中國
    • 印度
    • 韓國
    • 泰國
    • 澳洲
  • 拉丁美洲
    • 拉丁美洲研究蛋白質市場，2018-2030 年
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 2018 年至 2030 年中東和非洲研究蛋白質市場
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭格局

  • 公司分類
  • 戰略地圖
  • Company Position Analysis, 2024
  • 公司簡介/上市公司
    • Thermo Fisher Scientific, Inc.
    • Abcam Plc
    • Miltenyi BIoTec
    • GenScript
    • Bio-Techne
    • Proteintech Group, Inc.
    • ACROBiosystems
    • Sino Biological, Inc.
    • ProSpec-Tany TechnoGene Ltd.
    • New England Biolabs
Product Code: GVR-4-68040-130-6

Research-grade Proteins Market Growth & Trends:

The global research-grade proteins market size is anticipated to reach USD 1.75 billion by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 11.49% from 2025 to 2030. The growing investments in research and development within the fields of cancer research and rising demand for personalized medicines are anticipated to contribute to the growth of the market. In addition, the rising government investments in numerous countries for various clinical studies are expected to drive the growth of the market. Moreover, the growing advancements in the biotechnology industry in developing countries are further driving the growth of the market over the forecast period.

The COVID-19 pandemic positively impacted the market due to the surge in research activities for developing vaccines, diagnostics, and therapeutics. As regulatory authorities focused on expediting the approval processes for vaccine candidates, the demand for contract manufacturing increased. Although novel vaccine platforms, such as mRNA vaccines, received significant attention, several recombinant protein vaccine alternatives were also being evaluated. For instance, in July 2022, Novavax, Inc.'s Nuvaxovid (NVX-CoV2373) recombinant protein-based COVID-19 vaccine received an expanded conditional marketing authorization for use in the EU. Furthermore, the pandemic highlighted the need for agile and flexible manufacturing abilities in biologics. This factor is expected to boost the competitive landscape and fuel market growth in the near future.

As per Global Genes, in October 2019, more than 400 million people globally are living with rare and genetic diseases. This figure indicates the dire need for treatments and the betterment of clinical settings as well as health awareness. The need for advanced research and drug targeting mechanisms knowledge is crucial for medicine development. Many regions have developed biobanks from cohort programs to provide researchers with high-quality samples for revolutionizing treatment efforts. This is expected to result in an increased focus on biomarkers discovery for various conditions. Thus, initiatives and government interest in research activities for building a better healthcare infrastructure are expected to enhance the applications of research-grade proteins, consequently driving market growth.

However, protein production is a time-consuming activity, which often requires high maintenance of the operating conditions during the procedure. Even with the high and ever-increasing demand for these recombinant products, support from regulatory bodies is still evolving at a slower pace. Research-grade proteins are usually manufactured via a host or an expression system, where the gene specific to the desired product is expressed through stages of transfection and bacterial transformation or viral transduction. This complex process often has the disadvantage of over-expression of untargeted regions and even utilizes more time. Thus, the absence of specific guidelines and regulations for recombinant technology is a major factor hindering the booming market of research-grade proteins.

Research-grade Proteins Market Report Highlights:

  • Based on product, the cytokines & growth factors segment dominated the market with the largest revenue share of 23.61% in 2024 and the segment is anticipated to grow with the fastest CAGR of 17.62% over the forecast period. This can be attributed to its role in various clinical studies for drug discovery and development
  • Based on host cell, the mammalian cells segment dominated the market with the largest revenue share of 55.73% in 2024. The large share is primarily due to its similar biological makeup to human cells, which helps in the production of biopharmaceuticals, including monoclonal antibodies, vaccines, and many more
  • Based on end-use, the pharmaceutical & biotechnology companies segment held the largest market share of 61.48% in 2024. Due to the increasing number of research activities for drug discoveries & development and the growing demand for personalized medicines, the demand for research-grade proteins is projected to boost over the forecast period
  • Based on region, North America dominated the market with a revenue share of 44.47% in 2024. This large share is attributed to the presence of major market players and robust healthcare infrastructure. These factors are anticipated to boost the market for research-grade proteins in the region over the forecast period

Table of Contents

Chapter 1. Research-grade Proteins Market: Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Product Segment
    • 1.2.2. Host Cell Segment
    • 1.2.3. End Use Segment
  • 1.3. Research Assumptions
  • 1.4. Information Procurement
    • 1.4.1. Primary Research
  • 1.5. Information or Data Analysis
  • 1.6. Market Formulation & Validation
  • 1.7. Market Model
  • 1.8. Global Market: CAGR Calculation
  • 1.9. Objectives

Chapter 2. Research-grade Proteins Market: Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Research-grade Proteins Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Trends and Outlook
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
      • 3.3.1.1. Increasing use of recombinant proteins in research activities
      • 3.3.1.2. Growing research activities for drug discovery and precision medicine
      • 3.3.1.3. Rising adoption of biologics & biosimilars
    • 3.3.2. Market Restraint Analysis
      • 3.3.2.1. Regulatory and safety concerns regarding protein production
      • 3.3.2.2. Dearth of skilled personnel and expertise
  • 3.4. Business Environment Analysis
    • 3.4.1. PESTEL Analysis
    • 3.4.2. Porter's Five Forces Analysis
    • 3.4.3. COVID-19 Impact Analysis

Chapter 4. Product Business Analysis

  • 4.1. Product Segment Dashboard
  • 4.2. Research-grade Proteins Market: Product Movement Analysis
  • 4.3. Global Research-Grade Proteins Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.4. Cytokines & Growth Factors
    • 4.4.1. Cytokines & Growth Factors Market, 2018 - 2030 (USD Million)
    • 4.4.2. Interferons (IFNs)
      • 4.4.2.1. Interferons (IFNs) Market, 2018 - 2030 (USD Million)
    • 4.4.3. Interleukins (ILs)
      • 4.4.3.1. Interleukins (ILs) Market, 2018 - 2030 (USD Million)
    • 4.4.4. Others
      • 4.4.4.1. Others Market, 2018 - 2030 (USD Million)
  • 4.5. Antibodies
    • 4.5.1. Antibodies, 2018 - 2030 (USD Million)
  • 4.6. Immune Checkpoint Proteins
    • 4.6.1. Immune Checkpoint Proteins Market, 2018 - 2030 (USD Million)
  • 4.7. Virus Antigens
    • 4.7.1. Virus Antigens Market, 2018 - 2030 (USD Million)
  • 4.8. Enzymes
    • 4.8.1. Enzymes Market, 2018 - 2030 (USD Million)
    • 4.8.2. Kinases
      • 4.8.2.1. Kinases Market, 2018 - 2030 (USD Million)
    • 4.8.3. Metabolic Enzymes
      • 4.8.3.1. Metabolic Enzymes Market, 2018 - 2030 (USD Million)
    • 4.8.4. Others
      • 4.8.4.1. Others Market, 2018 - 2030 (USD Million)
  • 4.9. Recombinant Regulatory Proteins
    • 4.9.1. Recombinant Regulatory Proteins Market, 2018 - 2030 (USD Million)
  • 4.10. Hormones
    • 4.10.1. Hormones Market, 2018 - 2030 (USD Million)
  • 4.11. Others
    • 4.11.1. Others Market, 2018 - 2030 (USD Million)

Chapter 5. Host Cell Business Analysis

  • 5.1. Host Cell Segment Dashboard
  • 5.2. Research-grade Proteins Market: Host Cell Movement Analysis
  • 5.3. Global Research-Grade Proteins Market Size & Trend Analysis, by Host Cell, 2018 to 2030 (USD Million)
  • 5.4. Mammalian Cells
    • 5.4.1. Mammalian Cells Market, 2018 - 2030 (USD Million)
  • 5.5. Bacterial Cells
    • 5.5.1. Bacterial Cells Market, 2018 - 2030 (USD Million)
  • 5.6. Yeast & Fungi
    • 5.6.1. Yeast & Fungi Market, 2018 - 2030 (USD Million)
  • 5.7. Insect Cells
    • 5.7.1. Insect Cells Market, 2018 - 2030 (USD Million)
  • 5.8. Others
    • 5.8.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. End Use Business Analysis

  • 6.1. End Use Segment Dashboard
  • 6.2. Research-grade Proteins Market: End Use Movement Analysis
  • 6.3. Global Research-Grade Proteins Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 6.4. Pharmaceutical & Biotechnology Companies
    • 6.4.1. Pharmaceutical & Biotechnology Companies Market, 2018 - 2030 (USD Million)
  • 6.5. Academic & Research Institutes
    • 6.5.1. Academic & Research Institutes Market, 2018 - 2030 (USD Million)
  • 6.6. Others
    • 6.6.1. Others Market, 2018 - 2030 (USD Million)

Chapter 7. Regional Business Analysis

  • 7.1. Regional Dashboard
  • 7.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
  • 7.3. North America
    • 7.3.1. North America Research-grade Proteins Market, 2018 - 2030 (USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. Key Country Dynamics
      • 7.3.2.2. Competitive Scenario
      • 7.3.2.3. U.S. Research-grade Proteins Market, 2018 - 2030 (USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Competitive Scenario
      • 7.3.3.3. Canada Research-grade Proteins Market, 2018 - 2030 (USD Million)
  • 7.4. Europe
    • 7.4.1. Europe Research-grade Proteins Market, 2018 - 2030 (USD Million)
    • 7.4.2. UK
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Competitive Scenario
      • 7.4.2.3. UK Research-grade Proteins Market, 2018 - 2030 (USD Million)
    • 7.4.3. Germany
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Competitive Scenario
      • 7.4.3.3. Germany Research-grade Proteins Market, 2018 - 2030 (USD Million)
    • 7.4.4. Spain
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Competitive Scenario
      • 7.4.4.3. Spain Research-grade Proteins Market, 2018 - 2030 (USD Million)
    • 7.4.5. France
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Competitive Scenario
      • 7.4.5.3. France Research-grade Proteins Market, 2018 - 2030 (USD Million)
    • 7.4.6. Italy
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Competitive Scenario
      • 7.4.6.3. Italy Research-grade Proteins Market, 2018 - 2030 (USD Million)
    • 7.4.7. Denmark
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Competitive Scenario
      • 7.4.7.3. Denmark Research-grade Proteins Market, 2018 - 2030 (USD Million)
    • 7.4.8. Sweden
      • 7.4.8.1. Key Country Dynamics
      • 7.4.8.2. Competitive Scenario
      • 7.4.8.3. Sweden Research-grade Proteins Market, 2018 - 2030 (USD Million)
    • 7.4.9. Norway
      • 7.4.9.1. Key Country Dynamics
      • 7.4.9.2. Competitive Scenario
      • 7.4.9.3. Norway Research-grade Proteins Market, 2018 - 2030 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Asia-Pacific Research-grade Proteins Market, 2018 - 2030 (USD Million)
    • 7.5.2. Japan
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Japan Research-grade Proteins Market, 2018 - 2030 (USD Million)
    • 7.5.3. China
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. China Research-grade Proteins Market, 2018 - 2030 (USD Million)
    • 7.5.4. India
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. India Research-grade Proteins Market, 2018 - 2030 (USD Million)
    • 7.5.5. South Korea
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Competitive Scenario
      • 7.5.5.3. South Korea Research-grade Proteins Market, 2018 - 2030 (USD Million)
    • 7.5.6. Thailand
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Competitive Scenario
      • 7.5.6.3. Thailand Research-grade Proteins Market, 2018 - 2030 (USD Million)
    • 7.5.7. Australia
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Competitive Scenario
      • 7.5.7.3. Australia Research-grade Proteins Market, 2018 - 2030 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Latin America Research-grade Proteins Market, 2018 - 2030 (USD Million)
    • 7.6.2. Brazil
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Brazil Research-grade Proteins Market, 2018 - 2030 (USD Million)
    • 7.6.3. Argentina
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Argentina Research-grade Proteins Market, 2018 - 2030 (USD Million)
  • 7.7. MEA
    • 7.7.1. MEA Research-grade Proteins Market, 2018 - 2030 (USD Million)
    • 7.7.2. South Africa
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Competitive Scenario
      • 7.7.2.3. South Africa Research-grade Proteins Market, 2018 - 2030 (USD Million)
    • 7.7.3. Saudi Arabia
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Competitive Scenario
      • 7.7.3.3. Saudi Arabia Research-grade Proteins Market, 2018 - 2030 (USD Million)
    • 7.7.4. UAE
      • 7.7.4.1. Key Country Dynamics
      • 7.7.4.2. Competitive Scenario
      • 7.7.4.3. UAE Research-grade Proteins Market, 2018 - 2030 (USD Million)
    • 7.7.5. Kuwait
      • 7.7.5.1. Key Country Dynamics
      • 7.7.5.2. Competitive Scenario
      • 7.7.5.3. Kuwait Research-grade Proteins Market, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Position Analysis, 2024
  • 8.4. Company Profiles/Listing
    • 8.4.1. Thermo Fisher Scientific, Inc.
      • 8.4.1.1. Company Overview
      • 8.4.1.2. Financial Performance
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Strategic Initiatives
    • 8.4.2. Abcam Plc
      • 8.4.2.1. Company Overview
      • 8.4.2.2. Financial Performance
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Strategic Initiatives
    • 8.4.3. Miltenyi Biotec
      • 8.4.3.1. Company Overview
      • 8.4.3.2. Product Benchmarking
      • 8.4.3.3. Strategic Initiatives
    • 8.4.4. GenScript
      • 8.4.4.1. Company Overview
      • 8.4.4.2. Financial Performance
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Strategic Initiatives
    • 8.4.5. Bio-Techne
      • 8.4.5.1. Company Overview
      • 8.4.5.2. Financial Performance
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Strategic Initiatives
    • 8.4.6. Proteintech Group, Inc.
      • 8.4.6.1. Company Overview
      • 8.4.6.2. Product Benchmarking
      • 8.4.6.3. Strategic Initiatives
    • 8.4.7. ACROBiosystems
      • 8.4.7.1. Company Overview
      • 8.4.7.2. Product Benchmarking
      • 8.4.7.3. Strategic Initiatives
    • 8.4.8. Sino Biological, Inc.
      • 8.4.8.1. Company Overview
      • 8.4.8.2. Product Benchmarking
      • 8.4.8.3. Strategic Initiatives
    • 8.4.9. ProSpec-Tany TechnoGene Ltd.
      • 8.4.9.1. Company Overview
      • 8.4.9.2. Product Benchmarking
      • 8.4.9.3. Strategic Initiatives
    • 8.4.10. New England Biolabs
      • 8.4.10.1. Company Overview
      • 8.4.10.2. Product Benchmarking
      • 8.4.10.3. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 North America research-grade proteins market, by country, 2018 - 2030 (USD Million)
  • Table 4 North America research-grade proteins market, by product, 2018 - 2030 (USD Million)
  • Table 5 North America research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
  • Table 6 North America research-grade proteins market, by end use, 2018 - 2030 (USD Million)
  • Table 7 U.S. research-grade proteins market, by product, 2018 - 2030 (USD Million)
  • Table 8 U.S research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
  • Table 9 U.S research-grade proteins market, by end use, 2018 - 2030 (USD Million)
  • Table 10 Canada research-grade proteins market, by product, 2018 - 2030 (USD Million)
  • Table 11 Canada research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
  • Table 12 Canada research-grade proteins market, by end use, 2018 - 2030 (USD Million)
  • Table 13 Mexico research-grade proteins market, by product, 2018 - 2030 (USD Million)
  • Table 14 Mexico research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
  • Table 15 Mexico research-grade proteins market, by end use, 2018 - 2030 (USD Million)
  • Table 16 Europe research-grade proteins market, by country, 2018 - 2030 (USD Million)
  • Table 17 Europe research-grade proteins market, by product, 2018 - 2030 (USD Million)
  • Table 18 Europe research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
  • Table 19 Europe research-grade proteins market, by end use, 2018 - 2030 (USD Million)
  • Table 20 UK research-grade proteins market, by product, 2018 - 2030 (USD Million)
  • Table 21 UK research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
  • Table 22 UK research-grade proteins market, by end use, 2018 - 2030 (USD Million)
  • Table 23 Germany research-grade proteins market, by product, 2018 - 2030 (USD Million)
  • Table 24 Germany research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
  • Table 25 Germany research-grade proteins market, by end use, 2018 - 2030 (USD Million)
  • Table 26 France research-grade proteins market, by product, 2018 - 2030 (USD Million)
  • Table 27 France research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
  • Table 28 France research-grade proteins market, by end use, 2018 - 2030 (USD Million)
  • Table 29 Italy research-grade proteins market, by product, 2018 - 2030 (USD Million)
  • Table 30 Italy research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
  • Table 31 Italy research-grade proteins market, by end use, 2018 - 2030 (USD Million)
  • Table 32 Spain research-grade proteins market, by product, 2018 - 2030 (USD Million)
  • Table 33 Spain research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
  • Table 34 Spain research-grade proteins market, by end use, 2018 - 2030 (USD Million)
  • Table 35 Denmark research-grade proteins market, by product, 2018 - 2030 (USD Million)
  • Table 36 Denmark research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
  • Table 37 Denmark research-grade proteins market, by end use, 2018 - 2030 (USD Million)
  • Table 38 Sweden research-grade proteins market, by product, 2018 - 2030 (USD Million)
  • Table 39 Sweden research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
  • Table 40 Sweden research-grade proteins market, by end use, 2018 - 2030 (USD Million)
  • Table 41 Norway research-grade proteins market, by product, 2018 - 2030 (USD Million)
  • Table 42 Norway research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
  • Table 43 Norway research-grade proteins market, by end use, 2018 - 2030 (USD Million)
  • Table 44 Asia Pacific research-grade proteins market, by country, 2018 - 2030 (USD Million)
  • Table 45 Asia Pacific research-grade proteins market, by product, 2018 - 2030 (USD Million)
  • Table 46 Asia Pacific research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific research-grade proteins market, by end use, 2018 - 2030 (USD Million)
  • Table 48 China research-grade proteins market, by product, 2018 - 2030 (USD Million)
  • Table 49 China research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
  • Table 50 China research-grade proteins market, by end use, 2018 - 2030 (USD Million)
  • Table 51 Japan research-grade proteins market, by product, 2018 - 2030 (USD Million)
  • Table 52 Japan research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
  • Table 53 Japan research-grade proteins market, by end use, 2018 - 2030 (USD Million)
  • Table 54 India research-grade proteins market, by product, 2018 - 2030 (USD Million)
  • Table 55 India research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
  • Table 56 India research-grade proteins market, by end use, 2018 - 2030 (USD Million)
  • Table 57 South Korea research-grade proteins market, by product, 2018 - 2030 (USD Million)
  • Table 58 South Korea research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
  • Table 59 South Korea research-grade proteins market, by end use, 2018 - 2030 (USD Million)
  • Table 60 Australia research-grade proteins market, by product, 2018 - 2030 (USD Million)
  • Table 61 Australia research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
  • Table 62 Australia research-grade proteins market, by end use, 2018 - 2030 (USD Million)
  • Table 63 Thailand research-grade proteins market, by product, 2018 - 2030 (USD Million)
  • Table 64 Thailand research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
  • Table 65 Thailand research-grade proteins market, by end use, 2018 - 2030 (USD Million)
  • Table 66 Latin America research-grade proteins market, by country, 2018 - 2030 (USD Million)
  • Table 67 Latin America research-grade proteins market, by product, 2018 - 2030 (USD Million)
  • Table 68 Latin America research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
  • Table 69 Latin America research-grade proteins market, by end use, 2018 - 2030 (USD Million)
  • Table 70 Brazil research-grade proteins market, by product, 2018 - 2030 (USD Million)
  • Table 71 Brazil research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
  • Table 72 Brazil research-grade proteins market, by end use, 2018 - 2030 (USD Million)
  • Table 73 Argentina research-grade proteins market, by product, 2018 - 2030 (USD Million)
  • Table 74 Argentina research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
  • Table 75 Argentina research-grade proteins market, by end use, 2018 - 2030 (USD Million)
  • Table 76 Middle East & Africa research-grade proteins market, by country, 2018 - 2030 (USD Million)
  • Table 77 Middle East & Africa research-grade proteins market, by product, 2018 - 2030 (USD Million)
  • Table 78 Middle East & Africa research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
  • Table 79 Middle East & Africa research-grade proteins market, by end use, 2018 - 2030 (USD Million)
  • Table 80 South Africa research-grade proteins market, by product, 2018 - 2030 (USD Million)
  • Table 81 South Africa research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
  • Table 82 South Africa research-grade proteins market, by end use, 2018 - 2030 (USD Million)
  • Table 83 Saudi Arabia research-grade proteins market, by product, 2018 - 2030 (USD Million)
  • Table 84 Saudi Arabia research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
  • Table 85 Saudi Arabia research-grade proteins market, by end use, 2018 - 2030 (USD Million)
  • Table 86 UAE research-grade proteins market, by product, 2018 - 2030 (USD Million)
  • Table 87 UAE research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
  • Table 88 UAE research-grade proteins market, by end use, 2018 - 2030 (USD Million)
  • Table 89 Kuwait research-grade proteins market, by product, 2018 - 2030 (USD Million)
  • Table 90 Kuwait research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
  • Table 91 Kuwait research-grade proteins market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Market summary
  • Fig. 4 Market segmentation & scope
  • Fig. 5 Market size and growth prospects
  • Fig. 6 Global research-grade proteins market- Key market driver analysis
  • Fig. 7 Global research-grade proteins market - Key market restraint analysis
  • Fig. 8 Global research-grade proteins market - Porter's analysis
  • Fig. 9 Global research-grade proteins market - PESTEL analysis
  • Fig. 10 Global research-grade proteins market: Product outlook key takeaways
  • Fig. 11 Global research-grade proteins market: Product movement analysis
  • Fig. 12 Cytokines & growth factors market estimates, 2018 - 2030 (USD Million)
  • Fig. 13 Interferons (IFNs) market estimates, 2018 - 2030 (USD Million)
  • Fig. 14 Interleukins (ILs) market estimates, 2018 - 2030 (USD Million)
  • Fig. 15 Others market estimates, 2018 - 2030 (USD Million)
  • Fig. 16 Antibodies market estimates, 2018 - 2030 (USD Million)
  • Fig. 17 Immune checkpoint proteins market estimates, 2018 - 2030 (USD Million)
  • Fig. 18 Virus antigens market estimates, 2018 - 2030 (USD Million)
  • Fig. 19 Enzymes market estimates, 2018 - 2030 (USD Million)
  • Fig. 20 Kinases market estimates, 2018 - 2030 (USD Million)
  • Fig. 21 Metabolic enzymes market estimates, 2018 - 2030 (USD Million)
  • Fig. 22 Others market estimates, 2018 - 2030 (USD Million)
  • Fig. 23 Recombinant regulatory proteins market estimates, 2018 - 2030 (USD Million)
  • Fig. 24 Hormones market estimates, 2018 - 2030 (USD Million)
  • Fig. 25 Others market estimates, 2018 - 2030 (USD Million)
  • Fig. 26 Global research-grade proteins market: Host cells outlook key takeaways
  • Fig. 27 Global research-grade proteins market: Host cells movement analysis
  • Fig. 28 Mammalian cells market estimates, 2018 - 2030 (USD Million)
  • Fig. 29 Bacterial cells market estimates, 2018 - 2030 (USD Million)
  • Fig. 30 Yeast & fungi market estimates, 2018 - 2030 (USD Million)
  • Fig. 31 Insect cells market estimates, 2018 - 2030 (USD Million)
  • Fig. 32 Others market estimates, 2018 - 2030 (USD Million)
  • Fig. 33 Global research-grade proteins market: End use outlook key takeaways
  • Fig. 34 Global research-grade proteins market: End use movement analysis
  • Fig. 35 Pharmaceutical & biotechnology companies market estimates, 2018 - 2030 (USD Million)
  • Fig. 36 Academic & research institutes market estimates, 2018 - 2030 (USD Million)
  • Fig. 37 Others market estimates, 2018 - 2030 (USD Million)
  • Fig. 38 Regional marketplace: Key takeaways
  • Fig. 39 Global research-grade proteins market: Regional movement analysis
  • Fig. 40 North America research-grade proteins market, 2018 - 2030 (USD Million)
  • Fig. 41 U.S. research-grade proteins market, 2018 - 2030 (USD Million)
  • Fig. 42 Canada research-grade proteins market, 2018 - 2030 (USD Million)
  • Fig. 43 Mexico research-grade proteins market, 2018 - 2030 (USD Million)
  • Fig. 44 Europe research-grade proteins market, 2018 - 2030 (USD Million)
  • Fig. 45 UK research-grade proteins market, 2018 - 2030 (USD Million)
  • Fig. 46 Germany research-grade proteins market, 2018 - 2030 (USD Million)
  • Fig. 47 France research-grade proteins market, 2018 - 2030 (USD Million)
  • Fig. 48 Spain research-grade proteins market, 2018 - 2030 (USD Million)
  • Fig. 49 Italy research-grade proteins market, 2018 - 2030 (USD Million)
  • Fig. 50 Denmark research-grade proteins market, 2018 - 2030 (USD Million)
  • Fig. 51 Sweden research-grade proteins market, 2018 - 2030 (USD Million)
  • Fig. 52 Norway research-grade proteins market, 2018 - 2030 (USD Million)
  • Fig. 53 Asia Pacific research-grade proteins market, 2018 - 2030 (USD Million)
  • Fig. 54 Japan research-grade proteins market, 2018 - 2030 (USD Million)
  • Fig. 55 China research-grade proteins market, 2018 - 2030 (USD Million)
  • Fig. 56 India research-grade proteins market, 2018 - 2030 (USD Million)
  • Fig. 57 South Korea research-grade proteins market, 2018 - 2030 (USD Million)
  • Fig. 58 Australia research-grade proteins market, 2018 - 2030 (USD Million)
  • Fig. 59 Thailand research-grade proteins market, 2018 - 2030 (USD Million)
  • Fig. 60 Latin America research-grade proteins market, 2018 - 2030 (USD Million)
  • Fig. 61 Brazil research-grade proteins market, 2018 - 2030 (USD Million)
  • Fig. 62 Argentina research-grade proteins market, 2018 - 2030 (USD Million)
  • Fig. 63 MEA research-grade proteins market, 2018 - 2030 (USD Million)
  • Fig. 64 South Africa research-grade proteins market, 2018 - 2030 (USD Million)
  • Fig. 65 Saudi Arabia research-grade proteins market, 2018 - 2030 (USD Million)
  • Fig. 66 UAE research-grade proteins market, 2018 - 2030 (USD Million)
  • Fig. 67 Kuwait research-grade proteins market, 2018 - 2030 (USD Million)
  • Fig. 68 Strategy framework